MA27744A1 - Procedes permettant d'empecher la glyconoylation de proteines - Google Patents

Procedes permettant d'empecher la glyconoylation de proteines

Info

Publication number
MA27744A1
MA27744A1 MA28477A MA28477A MA27744A1 MA 27744 A1 MA27744 A1 MA 27744A1 MA 28477 A MA28477 A MA 28477A MA 28477 A MA28477 A MA 28477A MA 27744 A1 MA27744 A1 MA 27744A1
Authority
MA
Morocco
Prior art keywords
preventing
glyconoylation
proteins
methods
microorganisms
Prior art date
Application number
MA28477A
Other languages
English (en)
Inventor
R Gardner Alan
D Sweitzer Thomas
H Taylor Alexander
S Patel Pramathesh
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MA27744A1 publication Critical patent/MA27744A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"Procédés pour empêcher la gluconoylation de protéines" La présente invention concerne un procédé pour empêcher la glyconoylation de polypeptides produits dans des micro-organismes. (Pas de figure d'abrégé)
MA28477A 2003-03-04 2005-09-05 Procedes permettant d'empecher la glyconoylation de proteines MA27744A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45168603P 2003-03-04 2003-03-04

Publications (1)

Publication Number Publication Date
MA27744A1 true MA27744A1 (fr) 2006-02-01

Family

ID=32962626

Family Applications (1)

Application Number Title Priority Date Filing Date
MA28477A MA27744A1 (fr) 2003-03-04 2005-09-05 Procedes permettant d'empecher la glyconoylation de proteines

Country Status (21)

Country Link
US (2) US8173396B2 (fr)
EP (1) EP1599578B1 (fr)
JP (1) JP2006520609A (fr)
KR (2) KR101146483B1 (fr)
CN (2) CN101942470A (fr)
AR (1) AR043719A1 (fr)
AT (1) ATE517985T1 (fr)
AU (2) AU2004217491B2 (fr)
BR (1) BRPI0408023A (fr)
CA (1) CA2517857A1 (fr)
ES (1) ES2369359T3 (fr)
IS (1) IS8029A (fr)
MA (1) MA27744A1 (fr)
MX (1) MXPA05009453A (fr)
MY (1) MY142798A (fr)
NO (1) NO20054532L (fr)
NZ (1) NZ570598A (fr)
RU (2) RU2005130650A (fr)
TW (1) TW200504218A (fr)
WO (1) WO2004078936A2 (fr)
ZA (1) ZA200506709B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2542391A (en) * 2015-09-17 2017-03-22 Annexin Pharmaceuticals Ab Process of manufacture
JP7304380B2 (ja) 2021-04-26 2023-07-06 プライムプラネットエナジー＆ソリューションズ株式会社 電極集電体および二次電池
WO2025252176A1 (fr) * 2024-06-05 2025-12-11 杭州明德生物医药技术有限公司 Vecteur d'expression et utilisation associée

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643758A (en) 1987-03-10 1997-07-01 New England Biolabs, Inc. Production and purification of a protein fused to a binding protein
ATE135403T1 (de) * 1987-03-10 1996-03-15 New England Biolabs Inc Herstellung und reinigung eines proteins, das mit einem bindungsprotein fusioniert ist
DE4028086A1 (de) 1990-09-05 1992-03-12 Boehringer Mannheim Gmbh Stabile 6-phosphogluconolactonase, verfahren zu deren gewinnung sowie verwendung des enzyms zur bestimmung
US5733762A (en) 1994-04-28 1998-03-31 I.D.M. Immuno-Designed Molecules Complexes of nucleic acid and polymer, their process of preparation and their use for the transfection of cells
US5948681A (en) 1996-08-14 1999-09-07 Children's Hospital Of Philadelphia Non-viral vehicles for use in gene transfer

Also Published As

Publication number Publication date
AR043719A1 (es) 2005-08-10
AU2009201136B2 (en) 2011-06-23
EP1599578A4 (fr) 2007-03-14
TW200504218A (en) 2005-02-01
US20090233333A1 (en) 2009-09-17
ATE517985T1 (de) 2011-08-15
WO2004078936A3 (fr) 2006-02-16
IS8029A (is) 2005-09-15
AU2004217491B2 (en) 2009-04-09
WO2004078936A2 (fr) 2004-09-16
ZA200506709B (en) 2006-08-30
US20120196372A1 (en) 2012-08-02
EP1599578B1 (fr) 2011-07-27
JP2006520609A (ja) 2006-09-14
KR20050107486A (ko) 2005-11-11
US8173396B2 (en) 2012-05-08
NZ570598A (en) 2010-03-26
RU2005130650A (ru) 2006-04-10
ES2369359T3 (es) 2011-11-29
CN1798836B (zh) 2011-04-27
CN1798836A (zh) 2006-07-05
CN101942470A (zh) 2011-01-12
EP1599578A2 (fr) 2005-11-30
MXPA05009453A (es) 2005-11-23
BRPI0408023A (pt) 2006-02-14
MY142798A (en) 2010-12-31
KR20110134514A (ko) 2011-12-14
RU2009149159A (ru) 2011-07-10
KR101146483B1 (ko) 2012-05-24
AU2004217491A1 (en) 2004-09-16
NO20054532L (no) 2005-11-24
AU2009201136A1 (en) 2009-04-09
CA2517857A1 (fr) 2004-09-16
NO20054532D0 (no) 2005-10-03

Similar Documents

Publication Publication Date Title
WO2003104418A3 (fr) Polypeptides reconstitues
DE60235212D1 (de) Fluoropyrrolidine als Dipeptidylpeptidasehemmer
EP1943348A4 (fr) Compositions, procedes et kits pour l'amplification d'acides nucleiques
DE60221983D1 (de) Fluoropyrrolidine als dipeptidyl-peptidase inhibitoren
EP1907590A4 (fr) Materiaux et procedes pour la generation de transcriptions d'acide nucleiques modifiee en 2'
EP1555324A4 (fr) Procede de defructosylation
WO2005047471A3 (fr) Procede a efficacite amelioree du systeme fret
AU2002343573A1 (en) Methods for detecting genetic haplotypes by interaction with probes
TW200508219A (en) Process for preparing optically pure active compounds
AU2003244370A1 (en) Substituted 4,4-difluoro-4-bora-3a, 4a-diaza-s-indacene compounds for 8-color dna sequencing
IL144247A0 (en) Novel odorant receptors in drosophila
EP1633271A4 (fr) Procede pour blanchir les dents
AU2003259222A1 (en) Method of diagnosing alzheimer's disease
WO2008056360A9 (fr) Composition à base de pois chiches
ATE423316T1 (de) Verfahren zum nachweis ungenügender bindung von magnesium an zelluläre membranen zum krankheitsnachweis
SG148154A1 (en) Benzannelated compounds as ppar activators
DE602004031129D1 (de) Verfahren zur herstellung von quetiapin
WO2003106385A3 (fr) Procede de criblage de composes fongitoxiques
ATE463468T1 (de) Verwendung von magnesiumphosphat zur wasserenthärtung
TW200504218A (en) Methods for preventing gluconoylation of proteins
FR2851947B1 (fr) Procede d'usinage d'une lentille ophtalmique.
AU2001226785A1 (en) Method, kit and dna probes for detecting a fungal species in clinical material
AU2003215086A1 (en) Method for detecting polymorphisms in nucleic acids
EP1967585A4 (fr) Procede pour l'amplification de genes
DE60321487D1 (de) Verfahren zur identifizierung und quantifizierung von proteinen, isoformen des angiotensin i umsetzenden enzyms